WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it expanded its Phase III OCEANIC clinical development program for the investigational drug asundexian (BAY2433334) by initiating a third ...
BOSTON--(BUSINESS WIRE)--A global research study is now available in Memphis, Tenn., for an investigational medication that may help patients with a history of atrial fibrillation (AFib) decrease ...
Sign up for CNN’s Eat, But Better: Mediterranean Style. Our eight-part guide shows you a delicious expert-backed eating lifestyle that will boost your health for ...
The study enrolled approximately 12,000 patients in the U.S. who were at least 70 years old with no history of atrial fibrillation. Roughly half the patients were randomly assigned to receive a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results